6 Buys Breaking Near 52-Week Highs

NEW YORK ( TheStreet) -- In today's market, investors must be willing to adapt or die. In fact I can probably drop the first part of that sentence and say simply, "investors must be willing to adapt or die," because the markets have always progressed. Sometimes slowly, and sometimes quickly, but the participants have not changed.

Take my trading approach as an example. While I am generally known for my aggressive shorting, I am trading to the long side more than ever.

There is a common saying that I imagine goes back to the creation of the Fed. Never fight God or the Fed. We knew QE3 was coming long before it was announced. How did we know? Because there is another common saying, "There are no coincidences on Wall Street."

If it's true that there are no coincidences on Wall Street (I believe it's true), we can safely assume that it's not a coincidence the S&P 500 ETF ( SPY) moved higher in front of the QE3 announcement.

Take a look at SPY's chart and look at the beginning of the media coverage about a possible QE3. If you believe the SPY increasing is no more than a coincidence in the face of higher unemployment, higher deficit spending, European woes and a Chinese slowdown, I know a guy who will sell you a bridge in San Francisco.

So, for now I'm not going to fight the Fed and I will continue to focus my attention toward stocks that hold the ability to maximize shareholder returns inside the current environment. In Six Buys Near 52-Week Highs I provided six stocks that as a group are up strongly. The one and only stock that didn't climb is Sirius XM Radio ( SIRI) , but after allowing for my suggestion to wait for dips and entering a covered call strategy, it's a winner too.

If you liked this article you might like

How to Eat Lunch With Billionaire Warren Buffett

Bank Stocks Move Higher as Fed Decides to Start Unwinding Balance Sheet

Jim Cramer on Equifax, Wells Fargo, Federal Reserve, FedEx, Adobe and Toshiba

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways

Target-Date Funds, Touted as a Retirement Panacea, Don't Always Deliver